Revatio Labeling Includes Warning On “Visual Disturbances”

Labeling for Pfizer's Revatio (sildenafil) includes a warning on the possibility of "visual disturbances" at doses higher than 20 mg three times daily for the treatment of pulmonary arterial hypertension